You can buy or sell Vermillion and other stocks, options, ETFs, and crypto commission-free!
Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Read More The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.
52 Week High
52 Week Low
Yahoo FinanceMar 12
Vermillion to Report Fourth Quarter and Year End 2018 Financial Results on Thursday, March 28
AUSTIN, Texas, March 12, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will report financial results for the fourth quarter and year ended December 31, 2018 on Thursday, March 28, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time. Thursday, March 28 th @ 4:30pm Eastern Time Domestic: 877-407-4018 International: 201-689-8471 Conference ID: 13688624 Webcast: http://public.vi...
Stock Price, News, & Analysis for Vermillion
Vermillion, Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovaria...
Available Mar 28, After Hours